Frankfurt - Delayed Quote EUR
ImmunityBio, Inc. (26CA.F)
2.6460
-0.0870
(-3.18%)
At close: June 13 at 9:55:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-370,159
-391,236
-366,757
-337,509
-274,419
Investing Cash Flow
27,505
-12,246
-30,470
27,297
-84,886
Financing Cash Flow
270,423
281,630
558,341
233,613
505,443
End Cash Position
61,138
143,912
265,787
104,965
181,280
Income Tax Paid Supplemental Data
7
15
8
2
9
Interest Paid Supplemental Data
83,999
92,318
77,192
35,442
2,106
Capital Expenditure
-6,748
-6,888
-30,584
-99,391
-33,563
Issuance of Capital Stock
--
111,357
110,103
60,427
164,530
Issuance of Debt
--
0
258,700
174,125
338,500
Repayment of Debt
-43
-64
-77
-58
0
Repurchase of Capital Stock
--
--
--
--
0
Free Cash Flow
-376,907
-398,124
-397,341
-436,900
-307,982
12/31/2021 - 3/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
38I.F Intellia Therapeutics, Inc.
6.79
-9.44%
UP0.F Ultragenyx Pharmaceutical Inc.
33.40
+3.73%
1FG.F FibroGen, Inc.
0.2563
+1.10%
4DN.MU Denali Therapeutics Inc.
12.91
-2.23%
2L9.F Blueprint Medicines Corporation
109.00
-0.91%
ALNEV.PA Neovacs S.A.
0.0030
+50.00%
ESLA Estrella Immunopharma, Inc.
0.9600
-4.95%
PI3.F Gubra A/S
72.50
-2.75%
VIRX Viracta Therapeutics, Inc.
0.0200
0.00%